Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04873362
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

Who this might be right for
Breast Cancer
Hoffmann-La Roche 1,188
Testing effectiveness (Phase 2)UnknownNCT03569696
What this trial is testing

Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy

Who this might be right for
Lymphoma, B-Cell
Meirav Kedmi MD 50
Not applicableUnknownNCT04341480
What this trial is testing

The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

Who this might be right for
Gynecological Cancer
Tongji Hospital 305
Testing effectiveness (Phase 2)UnknownNCT00082979
What this trial is testing

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Testing effectiveness (Phase 2)UnknownNCT03622827
What this trial is testing

Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Nanjing Medical University 120
Testing effectiveness (Phase 2)Ended earlyNCT00038142
What this trial is testing

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
M.D. Anderson Cancer Center 46
Large-scale testing (Phase 3)Active Not RecruitingNCT00798070
What this trial is testing

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

Who this might be right for
Breast Cancer
Karolinska University Hospital 2,017
Testing effectiveness (Phase 2)Active Not RecruitingNCT01220583
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923180
What this trial is testing

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Testing effectiveness (Phase 2)Looking for participantsNCT07182279
What this trial is testing

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
The Methodist Hospital Research Institute 29
Testing effectiveness (Phase 2)UnknownNCT01180504
What this trial is testing

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma
University Hospital Heidelberg 36
Not applicableEnded earlyNCT01052376
What this trial is testing

Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer

Who this might be right for
Inflammatory Bowel Disease (IBD)Familial Adenomatous Polyposis
Nantes University Hospital 73
Testing effectiveness (Phase 2)Ended earlyNCT03973918
What this trial is testing

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Who this might be right for
High Grade GliomaBRAF V600EBRAF V600K+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Early research (Phase 1)Study completedNCT02063724
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Very early researchEnded earlyNCT01292733
What this trial is testing

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

Who this might be right for
Ovarian DiseasesOvarian Neoplasms
Swedish Medical Center 534
Early research (Phase 1)Study completedNCT03066648
What this trial is testing

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+5 more
Novartis Pharmaceuticals 241
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655755
What this trial is testing

Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT06613035
What this trial is testing

Twice-per-weekSelinexor, 2 Days Melphalan

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 126
Testing effectiveness (Phase 2)Study completedNCT02340949
What this trial is testing

Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 180
Large-scale testing (Phase 3)Study completedNCT01382147
What this trial is testing

Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Prof. Dr. Wolfgang Hiddemann 396
Next Page